Intellia Therapeutics Inc buy Truist Financial Co.
Start price
24.06.24
/
50%
€23.43
Target price
24.06.25
€111.85
Performance (%)
-13.57%
Price
12:32
€20.25
Summary
This prediction is currently active. The prediction for Intellia Therapeutics Inc disappoints with a performance of -13.57%. This prediction currently runs until 24.06.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -4.534% | -4.534% |
| iShares Core DAX® | -0.372% | 5.236% |
| iShares Nasdaq 100 | -1.950% | 1.680% |
| iShares Nikkei 225® | -1.690% | 7.286% |
| iShares S&P 500 | -0.399% | 2.379% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $120.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat